The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Much Is The Corticosteroids Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?
The corticosteroids market has demonstrated substantial growth in recent years. This market is projected to expand from $5.93 billion in 2025 to reach $6.33 billion in 2026, driven by a compound annual growth rate (CAGR) of 6.7%. Its historical expansion can be attributed to factors such as the increasing prevalence of asthma and allergies, the established clinical efficacy of corticosteroids, the widespread adoption of steroid therapies within hospitals, enhanced awareness of inflammatory disease management, and the expansion of pharmaceutical manufacturing capacity.
The corticosteroids market is anticipated to show considerable growth in the upcoming years. It is forecast to expand to $8.34 billion in 2030, achieving a compound annual growth rate (CAGR) of 7.1%. This expected increase can be attributed to several factors including the rising burden of autoimmune and respiratory diseases, the development of more secure steroid formulations, the global aging population, improved healthcare accessibility in emerging economies, and increased funding for corticosteroid research. Notable trends during the forecast period are targeted corticosteroid formulations, low-dose and short-duration treatments, a surge in topical and inhaled corticosteroids, combination therapies with bronchodilators, and their expanding application in acute respiratory care.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2832&type=smp
What Key Drivers Are Influencing The Growth Of The Corticosteroids Market?
The expanding need for cancer therapies is set to drive the growth of the corticosteroid market in the future. Cancer treatment involves a range of approaches, including surgical procedures, chemotherapy, radiation therapy, immunotherapy, and specific targeted interventions, all aimed at eliminating cancerous cells and mitigating symptoms. This growing demand for cancer care stems from multiple factors, such as a higher occurrence of cancer cases, enhanced public awareness and screening efforts, better availability of healthcare, and the provision of supportive care options. Corticosteroids play a crucial role by easing symptoms and improving the tolerance of cancer treatments, which in turn leads to better results for patients and reinforces the rising need for holistic cancer management. As an illustration, in May 2024, the UK’s National Health Service (NHS) indicated that treatment levels reached an unprecedented peak, with more than 1,400 patients starting cancer treatment daily on working days. From April 2023 to March 2024, approximately 340,000 individuals received their initial cancer treatment. Consequently, the increased requirement for cancer treatment propels the expansion of the corticosteroid market.
What Major Segment Divisions Exist Within The Corticosteroids Market?
The corticosteroids market covered in this report is segmented –
1) By Product: Glucocorticoids, Mineralocorticoids
2) By Application: Skin Allergies, Rheumatology Indications, Endocrinology, Acute Respiratory Diseases, Other Applications
3) By End User: Hospitals, Clinics, Research Institutes, Other End Users
Subsegments:
1) By Glucocorticoids: Hydrocortisone, Prednisone, Dexamethasone, Methylprednisolone, Triamcinolone, Betamethasone, Other Glucocorticoids
2) By Mineralocorticoids: Fludrocortisone, Aldosterone, Other Mineralocorticoids
How Are Trends Shaping The Direction Of The Corticosteroids Market?
Leading companies within the corticosteroids market are engaged in developing innovative products, such as rescue medications, to cater to broader customer bases, achieve greater sales, and boost revenue. A rescue medication refers to a type of treatment or drug administered for swift and immediate relief from acute and severe symptoms of a medical condition or a sudden worsening of a chronic ailment. As an illustration, in January 2023, AstraZeneca PLC, a UK-based pharmaceutical company, announced the FDA approval for Airsupra (albuterol/budesonide). A distinguishing feature of this product is its designation as the first-in-class pressurized metered-dose inhaler (pMDI), functioning as a fixed-dose combination rescue medication. It incorporates albuterol, a short-acting beta2-agonist (SABA), and budesonide, an inhaled corticosteroid (ICS) endowed with anti-inflammatory characteristics. This product is indicated for individuals aged 18 years and above and can be employed as needed for addressing or preventing bronchoconstriction. It also assists in decreasing the risk of asthma exacerbations. This combination is accessible in the United States and is under development by AstraZeneca in collaboration with Avillion.
Which Companies Are Leading Innovation In The Corticosteroids Market?
Major companies operating in the corticosteroids market are McKesson Corporation, Pfizer Inc., Johnson and Johnson Services Inc., Merck & Co.Inc., Bayer AG, Novartis International AG., Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy’s Laboratories Ltd., Endo International plc, Lupin Limited, Mallinckrodt Pharmaceuticals Ltd., LEO Pharma A/S, Glenmark Pharmaceuticals Ltd., Wockhardt Limited, Allergan plc, Hikma Pharmaceuticals pl.
Read the full corticosteroids market report here:
https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report
Which Region Is Expected To Register The Fastest Growth In The Corticosteroids Market?
North America was the largest region in the corticosteroids therapy market share in 2025. Middle East is expected to be the largest growing region in the global corticosteroids market during the forecast period. The regions covered in the corticosteroids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Corticosteroids Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2832&type=smp
Browse Through More Reports Similar to the Global Corticosteroids Market 2026, By The Business Research Company
Drugs For Immunotherapy Market Report 2026
https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report
Metabolic Disorders Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/metabolic-disorders-drugs-global-market-report
Musculoskeletal Disorder Drugs Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model